BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10756334)

  • 1. Mechanisms of protection of cationic lipid-DNA complexes during lyophilization.
    Allison SD; Anchordoquy TJ
    J Pharm Sci; 2000 May; 89(5):682-91. PubMed ID: 10756334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis.
    Allison SD; Molina MC; Anchordoquy TJ
    Biochim Biophys Acta; 2000 Sep; 1468(1-2):127-38. PubMed ID: 11018658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.
    Mohammed-Saeid W; Michel D; El-Aneed A; Verrall RE; Low NH; Badea I
    J Pharm Pharm Sci; 2012; 15(4):548-67. PubMed ID: 23106958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lyophilization of cationic lipid-protamine-DNA (LPD) complexes.
    Li B; Li S; Tan Y; Stolz DB; Watkins SC; Block LH; Huang L
    J Pharm Sci; 2000 Mar; 89(3):355-64. PubMed ID: 10707016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of nonviral vector particle size during the freezing step of the lyophilization process is insufficient for preservation of activity: insight from other structural indicators.
    Molina MC; Allison SD; Anchordoquy TJ
    J Pharm Sci; 2001 Oct; 90(10):1445-55. PubMed ID: 11745704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of PEGylation on the preservation of cationic lipid/DNA complexes during freeze-thawing and lyophilization.
    Armstrong TK; Girouard LG; Anchordoquy TJ
    J Pharm Sci; 2002 Dec; 91(12):2549-58. PubMed ID: 12434398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation strategies to minimize oxidative damage in lyophilized lipid/DNA complexes during storage.
    Molina MD; Anchordoquy TJ
    J Pharm Sci; 2008 Dec; 97(12):5089-105. PubMed ID: 18399563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stability of lyophilized lipid/DNA complexes during prolonged storage.
    Molina Md; Armstrong TK; Zhang Y; Patel MM; Lentz YK; Anchordoquy TJ
    J Pharm Sci; 2004 Sep; 93(9):2259-73. PubMed ID: 15295787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance of transfection rates and physical characterization of lipid/DNA complexes after freeze-drying and rehydration.
    Anchordoquy TJ; Carpenter JF; Kroll DJ
    Arch Biochem Biophys; 1997 Dec; 348(1):199-206. PubMed ID: 9390192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspects of nonviral gene therapy: correlation of molecular parameters with lipoplex structure and transfection efficacy in pyridinium-based cationic lipids.
    Parvizi P; Jubeli E; Raju L; Khalique NA; Almeer A; Allam H; Manaa MA; Larsen H; Nicholson D; Pungente MD; Fyles TM
    Int J Pharm; 2014 Jan; 461(1-2):145-56. PubMed ID: 24296044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres.
    Takashima Y; Saito R; Nakajima A; Oda M; Kimura A; Kanazawa T; Okada H
    Int J Pharm; 2007 Oct; 343(1-2):262-9. PubMed ID: 17628365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal contaminants promote degradation of lipid/DNA complexes during lyophilization.
    Molina Md; Anchordoquy TJ
    Biochim Biophys Acta; 2007 Mar; 1768(3):669-77. PubMed ID: 17224131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight dextrans stabilize nonviral vectors during lyophilization at low osmolalities: concentrating suspensions by rehydration to reduced volumes.
    Anchordoquy TJ; Armstrong TK; Molina Md
    J Pharm Sci; 2005 Jun; 94(6):1226-36. PubMed ID: 15858857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immobilization of nonviral vectors during the freezing step of lyophilization.
    Armstrong TK; Anchordoquy TJ
    J Pharm Sci; 2004 Nov; 93(11):2698-709. PubMed ID: 15389673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector.
    Vighi E; Montanari M; Hanuskova M; Iannuccelli V; Coppi G; Leo E
    Int J Pharm; 2013 Jan; 440(2):161-9. PubMed ID: 22982257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of lipid/DNA complexes during agitation and freeze-thawing.
    Anchordoquy TJ; Girouard LG; Carpenter JF; Kroll DJ
    J Pharm Sci; 1998 Sep; 87(9):1046-51. PubMed ID: 9724553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hydroxyethylated cholesterol-based cationic lipid for DNA delivery: effect of conditioning.
    Percot A; Briane D; Coudert R; Reynier P; Bouchemal N; Lièvre N; Hantz E; Salzmann JL; Cao A
    Int J Pharm; 2004 Jun; 278(1):143-63. PubMed ID: 15158957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sugars on storage stability of lyophilized liposome/DNA complexes with high transfection efficiency.
    Maitani Y; Aso Y; Yamada A; Yoshioka S
    Int J Pharm; 2008 May; 356(1-2):69-75. PubMed ID: 18249511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a lyophilized plasmid/LPEI polyplex formulation with long-term stability--A step closer from promising technology to application.
    Kasper JC; Schaffert D; Ogris M; Wagner E; Friess W
    J Control Release; 2011 May; 151(3):246-55. PubMed ID: 21223985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles.
    Howard MD; Lu X; Jay M; Dziubla TD
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1270-9. PubMed ID: 22235767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.